Skip to main content

Table 4 Bivariate analysis of prognostic factors for incidence of pathological fractures

From: The influence of orthopedic corsets on the incidence of pathological fractures in patients with spinal bone metastases after radiotherapy

  All Corset group No corset group
  OR 95 % CI p-value OR 95 % CI p-value OR 95 % CI p-value
Gender 0.797 0.503–1.262 0.333 0.727 0.369–1.434 0.358 0.862 0.461–1.612 0.642
KPS 0.843 0.535–1.327 0.461 0.753 0.387–1.465 0.403 0.930 0.500–1.731 0.819
NSCLC 0.604 0.376–0.969 0.036 0.566 0.285–1.126 0.105 0.645 0.336–1.237 0.186
Breast cancer 0.562 0.284–1.113 0.098 0.745 0.318–1.746 0.498 0.369 0.111–1.225 0.103
Kidney cancer 1.071 0.595–1.928 0.818 2.008 0.928–4.345 0.076 0.534 0.204–1.398 0.202
Localization 0.970 0.607–1.548 0.897 0.618 0.292–1.308 0.208 1.351 0.725–2.517 0.343
Chemotherapy 1.020 0.647–1.609 0.931 1.295 0.657–2.555 0.455 1.329 0.704–2.511 0.381
Stability before RT 0.937 0.595–1.474 0.777 0.647 0.298–1.406 0.271 1.155 0.586–2.276 0.677
Stability after 3 months 0.993 0.594–1.660 0.980 0.776 0.363–1.660 0.514 1.266 0.505–3.174 0.614
Stability after 6 months 0.939 0.537–1.642 0.826 0.587 0.256–1.343 0.207 1.682 0.493–5.740 0.406
Bisphosphonates 0.939 0.573–1.538 0.803 0.606 0.288–1.274 0.186 1.313 0.676–2.550 0.421
Number of metastases 1.314 0.826–2.090 0.249 1.689 0.829–3.442 0.149 0.683 0.365–1.277 0.232